Department of Internal Medicine, Infectiology and Pulmonology (incl. Pneumonological Oncology) CCM/CVK
Institutes
Projects
- A dose-escalation, placebo controlled, double-blind study exploring the safety, tolerability, pharmacokinetics and
- A long-term open-label rollover trial assessing the safety and tolerability of combination tipranavir and ritonavir
- A phase III open-label safety study of T-20/Ro 29-9800 (HIV-1 fusion inhibitor) in combination with oral antiretrov
- A phase III study: Operation combined with radiation versus radiation alone in patients with stage I-IIIA small cel
- A Phase IIIB open label clinical study to evaluate sefaty of GW433908) in the treatment of HIV-1 infected patients
- A phase IV study with PegIntron and Rebetrol in coinfected patients with chronic hepatitis C
- A phase IV study with PegIntron and Rebetrol in coinfected patients with chronic hepatitis C
- A placebo-controlled, dose escalation study in HIV-1 infected subjects to characterize the safety, tolerability and
- A Randomized Multicentric Phase III Study Evaluating Topotecan/Cisplatin versus Topotecan/Etoposid versus Etoposid/
- A Randomized, Open-Label, Phase III, International Study of Subcutaneous Recombinant IL-2 (Proleukin®) in Patients
- A randomized, open-label, two arm trial to compare the safety and antiretroviral efficacy of GW 433908/ritonavir QD
- Adrenomedullin and Permeability
- An open label, phase II study of ammprenavir/ritonavir, saquinavir/ritonavir or efavirenz in HIV-infected subjects
- An open-label, randomized, parallel group pharmacokinetics trial of tipranvir/ritonavir (TPV/RTV), alone or in comb
- An uncontrolled phase II study evaluating antitumor efficacy and safety of BAY 59-8862 in Patients with Taxane resi
- Apoptosis of inflammatory cells and bronchial myocytes in COPD
- Atazanavir (BMS-232632) For HIV Infected Individuals: An Early Access Program Phase: Illb
- C. pneumoniae - endothelial cell interaction
- Chlamydophila pneumoniae Infection of endothelial cells
- Clinical Study 20010145: A randomized, double blind, placebo-controlled study of subjects with previously untreated
- ClinSurv
- community acquired pneumonia network
- Efficacy and Safety of Trizivir plus Efavirenz (Quad-Therapy) Over 72 Weeks Versus Quad Therapy for 24 Weeks Follow
- Evaluation of the Safety and Antiviral Efficacy of a Novel HIV-1 Protease Inhibitor, BMS-232632, in Combination wi
- Habil - Moraxella catarrhalis
- Histonmod.f.Pneumokokken
- IL-15 and apoptosis
- Linezolid
- MedikatStudie
- Moxifloxacin MAP
- MOXIRAPID
- NBL III - TP 3.3.1.A - Dr. Hippenstiel
- Neoadjuvant Chemotherapy Protocol of Docetaxel/Carboplatin in the Treatment of Stage IIIA/IIIB NSCLC
- Phase I trial for advanced solid tumors
- Phase III chemotherapy study SCLC
- Phosphodiesterases and endothelial cell function
- PRI/EPO-GER-22, Epoetin alfa in NSCLC patients
- Randomized, open-label, comparative safety and efficacy study of tipranavir boosted with low dose ritonavir (TPV/R
- Randomized Phase II Study of Gemcitabin/Cisplatin followed by Docetaxel vs Gemcitabin / Docetaxel in Patients with
- Regulation of IL-10 synthesis in alveolar macrophages from sarcoidosis patients
- Role of adrenomedullin in LPS-dependent signaling in endothelial cells.
- Role of IL-15 dependent lymphocytes in pneumococcal peumonia
- SCH 417690: Rising Multiple Dose Assessment of Saefety, Tolerance, Pharmacokinetics, and Pharmacodynamics in HIV-1
- SCO100470 - phase III trial for salmeterol/fluticasone
- Serokonverter
- Standardized Cannabis Extract versus Delta-9-TC in Cancer Patients
- Surveillance der HIV-Krankhei
- Targretin Phase III study
- VENT-endobrochial valve for emphysema palliation
If the list does not contain any entry, the request was executed without results
Asthmaklinik - CVK